Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.

The Journal of Social Work Practice in the Addictions is a pivotal publication in the field of social work, dedicated to addressing the multifaceted challenges of addiction through rigorous research and practice. Published by Routledge Journals, Taylor & Francis Ltd, this journal has been a valuable resource since its inception in 2001 and continues to provide vital insights as it converges towards 2024. With a focus on empirical studies, theoretical advancements, and innovative practice approaches, it serves professionals and researchers alike who are engaged in the health and social sciences. Holding a respectable Q3 quartile ranking in both Health (Social Science) and Rehabilitation and a Q4 ranking in Social Work, it emphasizes the importance of interdisciplinary collaboration in tackling issues of addiction. The journal does not currently offer open access, ensuring exclusive dissemination to its dedicated readership, which includes practitioners, scholars, and students committed to improving outcomes for individuals affected by substance use disorders. As an essential platform within the community, it fosters knowledge exchange and supports evidence-based practice, thereby enhancing the field’s collective understanding of addiction-related challenges.

NICOTINE & TOBACCO RESEARCH, published by Oxford University Press, is a leading journal dedicated to advancing the understanding of nicotine and tobacco-related issues through rigorous research and analysis. Established in 1999, this esteemed journal has become a critical resource for scholars and practitioners in the fields of public health, environmental, and occupational health, maintaining a prestigious Q1 classification in its category as of 2023. With an impressive ranking of 67 out of 665 in the Scopus database, placing it in the 90th percentile, it is recognized for its high-quality contributions that resonate with current global health challenges. Although open access options are not available, the journal’s articles are accessible to a broad audience, ensuring that cutting-edge research reaches those who need it most. As it looks toward 2024 and beyond, NICOTINE & TOBACCO RESEARCH remains committed to promoting innovative research that informs policies and practices aimed at reducing tobacco use and its associated harms, thus playing a pivotal role in enhancing public health worldwide.

Canadian Journal of Addiction is a leading platform dedicated to advancing the understanding of addiction and its multifaceted impacts on individuals and society. Published by LIPPINCOTT WILLIAMS & WILKINS, this journal aims to foster rigorous research and discussion in the field of addiction studies, contributing significantly to the intersection of psychiatry and mental health. With its ISSN 2368-4720 and E-ISSN 2368-4739, the journal is indexed in Scopus and has been categorized in the Q3 quartile for 2023, reflecting its emerging influence amongst peers. The Canadian Journal of Addiction facilitates a vital exchange of ideas and findings, crucial for researchers, practitioners, and students alike, addressing pressing issues related to addiction through innovative studies and insightful reviews. Subscribers and readers benefit from the latest findings as they navigate through the dynamic landscape of addiction research, enriching both academic knowledge and practical applications.

Gaming Law Review: Economics Regulation Compliance and Policy is a groundbreaking journal published by Mary Ann Liebert, Inc., a renowned leader in disseminating cutting-edge research across various fields. Focused on the intersection of gaming, law, and economics, this journal delves into pressing issues regarding regulation, compliance, and policy surrounding the gaming industry. With an ISSN of 2572-5300 and E-ISSN 2572-5327, it serves as a crucial platform for academics, legal professionals, and policymakers to explore the dynamic landscape of gaming legislation and economic impact. While currently not open access, the journal allows for in-depth analysis and discussion necessary to navigate the complexities within this evolving field. With the rapid growth of the gaming sector, Gaming Law Review plays a vital role in contributing to an informed dialogue and providing researchers, professionals, and students access to pivotal insights and developments in gaming law and policy.

Welcome to the Journal of Addiction Medicine, a premier academic resource devoted to the field of addiction studies, published by LIPPINCOTT WILLIAMS & WILKINS. Since its inception in 2007, this esteemed journal has become a leader in disseminating groundbreaking research, with impressive rankings in the Q1 quartile across key disciplines such as Medicine (Miscellaneous), Pharmacology (Medical), and Psychiatry and Mental Health, reflecting its significance in the scholarly community. With an ISSN of 1932-0620 and an E-ISSN of 1935-3227, it caters to a diverse audience of researchers, clinicians, and students seeking to expand their understanding of addiction medicine. The journal's articles are primarily published in a non-open access format, ensuring high-quality research is accessible through institutional subscriptions. With a Scopus ranking that positions it within the top tiers of several relevant categories, the Journal of Addiction Medicine is essential for anyone committed to advancing knowledge in the field and addressing the complexities surrounding addiction.

JOURNAL OF DRUG ISSUES, published by SAGE PUBLICATIONS INC, serves as a pivotal platform for researchers and professionals dedicated to the multifaceted exploration of drug-related topics across various fields, including health, medicine, psychiatry, and public health. With an ISSN of 0022-0426 and an E-ISSN of 1945-1369, this esteemed journal has maintained a consistent output since its inception in 1971 and is set to continue its contributions through 2024. Reflecting its high academic standards, it has achieved a Q2 ranking in Health (Social Science) and Q3 rankings in several related categories, underscoring its relevance and influence among scholarly work. The journal is indexed in Scopus, with respectable rankings in various medical and health-related disciplines, highlighting its role as an essential resource for those invested in the vigorous discourse surrounding drug issues. Although not an open-access publication, the journal ensures that access to its extensive research findings remains available to a broad audience, solidifying its importance in advancing knowledge and informing best practices in the field.

Journal of Substance Use & Addiction Treatment is a premier scholarly publication dedicated to advancing the understanding and treatment of substance use disorders and addictive behaviors. Published by Elsevier Science Inc, this journal serves as a vital platform for researchers, clinicians, and students in the fields of psychology, psychiatry, public health, and addiction studies. With its commitment to Open Access, the journal facilitates wide dissemination of cutting-edge research, enabling practitioners and policymakers to access critical findings that inform treatment approaches and public health strategies. As an essential resource in addiction treatment and research, the Journal of Substance Use & Addiction Treatment aims to foster interdisciplinary collaboration and innovation, ultimately improving outcomes for individuals affected by addiction.

Substance Abuse Treatment, Prevention, and Policy is a premier open access journal published by BMC, dedicated to advancing the understanding and improvement of substance abuse treatment and prevention strategies. Since its inception in 2006, this journal has established itself as a significant resource in the fields of Health Policy and Psychiatry and Mental Health, proudly maintaining a strong reputation reflected in its 2023 Scopus rankings, which place it in the top quartiles of these categories. With an impactful focus on policy implications and evidence-based practices, the journal's comprehensive coverage supports the sharing of innovative research and perspectives aimed at mitigating substance abuse challenges worldwide. Open access since its launch, it ensures that vital research is readily available to researchers, practitioners, and students alike, facilitating collaboration and discourse in this critical area of public health. Its commitment to high-quality research is underscored by its rankings within the 78th percentile for Health Policy and 66th percentile for Psychiatry and Mental Health, highlighting its influence and relevance in addressing pressing issues in substance misuse.

ADDICTION, published by Wiley, is a highly regarded academic journal that serves the vibrant fields of Medicine and Psychiatry and Mental Health. With an impressive impact factor reflective of its significance—ranking in the top 8% and 7.5% of its categories respectively—this journal is esteemed for its rigorous peer-reviewed research which spans a wide array of topics related to addiction, including pharmacology, prevention, and treatment modalities. Since its inception in 1993, ADDICTION has continually provided a platform for innovative research, shaping the discourse and influencing clinical practices worldwide. This journal, based in the United Kingdom at a prestigious location in Hoboken, NJ, stands as a beacon for researchers, practitioners, and students alike, committed to advancing understanding and strategies to combat addiction-related challenges. Although it is not an Open Access publication, the journal's contribution to the field remains invaluable, ensuring that cutting-edge findings are disseminated widely among professionals dedicated to improving mental health outcomes.